Company intelligence / Profile preview

National Veterinary Institute

Debre Zeit, Ethiopia

Ownership: Private
Development stage: Other

Overview

NVI is a WHO and OIE-collaborating, ISO 9001:2015- and ISO/IEC 17025:2017-certified public vaccine manufacturer, focusing on commercial production, research, and development of veterinary vaccine products that are distributed across Ethiopia and more than 26 African countries. More than 300,000,000 doses per year are produced, targeting major livestock diseases.[1][3]

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Veterinary

Partnerships

Pan African Veterinary Vaccine Control Center (PANVAC)French Veterinary MissionVarious national and international institutes

Beyond the preview

Go deeper on National Veterinary Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on National Veterinary Institute.

Explore the full profile